This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $4,187.88, is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $4,187.88 and an ultimate completion date of December 11, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/11/25, 10:01 AM